Semax
Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10). Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, it has been the subject of extensive cognitive and neuroprotective research.
Mechanism of Action
Semax is believed to modulate brain-derived neurotrophic factor (BDNF) expression and interact with melanocortin receptors. Research suggests it may influence dopaminergic and serotonergic systems while providing neurotrophic support.
Research Background
Semax has been studied since the 1980s in Russia and has been the subject of over 400 published studies exploring its nootropic and neuroprotective properties.
Quick Specs
Every batch is independently tested for purity via HPLC-MS, endotoxins and heavy metals. Click here to view full COA documentation.
All products sold by Velora Peptides are for research use only by authorized research institutions and qualified researchers.